DC Chemicals' products qualify for U.S. tariff exemptions. We guarantee no price increases due to customs duties and maintain stable supply, continuing to deliver reliable research solutions to our American clients.
| Cas No.: | 1380392-05-1 |
| Chemical Name: | 5-(3-(4-(4-Chlorophenyl)piperidin-1-yl)propyl)pyrrolo[1,2-a]quinoxalin-4(5H)-one |
| Synonyms: | 5-(3-(4-(4-chlorophenyl)piperidin-1-yl)propyl)pyrrolo[1,2-a]quinoxalin-4(5H)-one;GTPL10390;WOSMCMULWWHMIV-UHFFFAOYSA-N;JMS 17-2;5-[3-[4-(4-Chlorophenyl)-1-piperidinyl]propyl]pyrrolo[1,2-a]quinoxalin-4(5H)-one;JMS-17-2 |
| SMILES: | ClC1C([H])=C([H])C(=C([H])C=1[H])C1([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])N2C(C3=C([H])C([H])=C([H])N3C3=C([H])C([H])=C([H])C([H])=C23)=O)C([H])([H])C1([H])[H] |
| Formula: | C25H26ClN3O |
| M.Wt: | 419.9464 |
| Purity: | >98% |
| Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | JMS-17-2 is a potent and selective CX3CR1 antagonist with an IC50 of 0.32 nM[1]. |
| Target: | CX3CR1:0.32 nM (IC50) |
| References: | [1]. Shen F, et al. Novel Small-Molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells. Mol Cancer Res. 2016 Jun;14(6):518-27. |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|
| 2018-0101 |
|